(Q39432071)

11 September 2017

title

Efficacy and tolerability of a new 7-day transdermal estradiol patch versus placebo in hysterectomized women with postmenopausal complaints (English)

1 reference

11 September 2017

0 references

von Holst T

1

1 reference

11 September 2017

Salbach B

series ordinal

2

1 reference

11 September 2017

publication date

1 February 2000

1 reference

11 September 2017

1 reference

11 September 2017

volume

34

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

143-153

1 reference

Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Transdermal estradiol. A review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Effects of treatment with oestradiol/levonorgestrel on bone, lipoproteins and hormone status in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Postmenopausal hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Treatment of postmenopausal osteoporosis with transdermal estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Oestrogen replacement therapy and cardiovascular disease in post-menopausal women. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Biologic effects of transdermal estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Efficacy, acceptability, and metabolic effects of transdermal estradiol in the management of postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

[Serum lipids in treatment with transdermal estradiol and oral norethisterone acetate]

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Cyclic hormonal replacement therapy after the menopause: Transdermal versus oral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Climacteric symptoms after oral and percutaneous hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Efficacy of transdermal estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Treatment of hot flashes with transdermal estradiol administration

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Procedures for comparing samples with multiple endpoints

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Efficacy and tolerance of Menorest compared to Premarin in the treatment of postmenopausal women. A randomised, multicentre, double-blind, double-dummy study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Double-masked, multicenter study of an estradiol matrix transdermal delivery system (Alora) versus placebo in postmenopausal women experiencing menopausal symptoms. Alora Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Efficacy and tolerability of Estraderm MX, a new estradiol matrix patch

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: randomised dose-response study. Aerodiol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2899%2900099-7

7 January 2021

10.1016/S0378-5122(99)00099-7

Identifiers

DOI

1 reference

11 September 2017

1 reference